Malignant Colon Neoplasm — Trials

Malignant Colon Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,196 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 225
Recruiting: 117
Ph III recruiting: 18
Growth YoY: −3.8%
Industry share: 14%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 26.9%
Trials / 1,000 deaths: 5.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (139)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00909558	Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer	suspended	Phase 1	24	Envita Medical Center, Inc.INDUSTRY	1	Feb 24, 2010	clinicaltrials
NCT00443573	Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer	suspended	Phase 1 / Phase 2	100	ARCA Biopharma, Inc.INDUSTRY	1	May 7, 2008	clinicaltrials